1 |
Identification of CSK as a systemic sclerosis genetic risk factor through genome wide association study follow-up
|
|
|
|
BASE
|
|
Show details
|
|
2 |
Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy.
|
|
|
|
BASE
|
|
Show details
|
|
3 |
Polymorphisms in the interleukin 4, interleukin 13 and corresponding receptor genes are not associated with systemic sclerosis and do not influence gene expression
|
|
|
|
BASE
|
|
Show details
|
|
4 |
Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis
|
|
|
|
BASE
|
|
Show details
|
|
5 |
Variants of PBEF predispose to systemic sclerosis and pulmonary arterial hypertension development
|
|
|
|
BASE
|
|
Show details
|
|
6 |
A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort
|
|
|
|
BASE
|
|
Show details
|
|
7 |
Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis
|
|
|
|
BASE
|
|
Show details
|
|
8 |
Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy
|
|
|
|
BASE
|
|
Show details
|
|
9 |
Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy
|
|
|
|
In: PLoS Genetics, 14-07-2011 (2011)
|
|
BASE
|
|
Show details
|
|
10 |
Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis
|
|
|
|
BASE
|
|
Show details
|
|
11 |
Identification of novel genetic markers associated with the clinical phenotypes of systemic sclerosis through a genome wide association strategy
|
|
|
|
BASE
|
|
Show details
|
|
12 |
Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis
|
|
|
|
BASE
|
|
Show details
|
|
13 |
Variants of PBEF predispose to systemic sclerosis and pulmonary arterial hypertension development
|
|
|
|
BASE
|
|
Show details
|
|
14 |
Polymorphisms in the interleukin 4, interleukin 13 and corresponding receptor genes are not associated with Systemic Sclerosis and do not influence gene expression
|
|
|
|
BASE
|
|
Show details
|
|
15 |
The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype
|
|
|
|
BASE
|
|
Show details
|
|
16 |
The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype
|
|
|
|
BASE
|
|
Show details
|
|
|
|